Stoke Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Stoke Therapeutics Inc
TickerSTOK
CIK #0001623526
CUSIP86150R107
SectorLife Sciences - Pharmaceutical Preparations
Address3 Preston Court, Bedford, MA 01730
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Stoke Therapeutics Inc 2018-11-02 90.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
Asothera Pharmaceuticals Inc 2014-11-24 0.8 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001623526] 10-K
[0001623526] 10-Q
[0001623526] 3
[0001623526] 4
[0001623526] 8-K
[0001623526] D
[0001623526] SC 13D
[0001623526] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Wellington Management Group LLP Stoke Therapeutics Inc [2026-05-15] 0.0
Toronto Dominion Bank Stoke Therapeutics Inc [2025-11-14] 0.0
FMR LLC Stoke Therapeutics Inc [2025-06-06] 0.0
BlackRock Portfolio Management LLC Stoke Therapeutics Inc [2025-04-15] 0.0
Baker Bros Advisors LP Stoke Therapeutics Inc [2024-11-14] 8.3
BlackRock Inc Stoke Therapeutics Inc [2024-07-08] 10.4
Cowen Financial Products LLC Stoke Therapeutics Inc [2024-02-26] 5.77
Lynx1 Capital Management LP Stoke Therapeutics Inc [2023-11-06] 6.0
Morgan Stanley Stoke Therapeutics Inc [2023-02-10] 6.2
Vanguard Group Inc Stoke Therapeutics Inc [2022-02-10] 5.2
Cowen Financial Products LLC Stoke Therapeutics Inc [2022-01-24] 5.09
Skorpios Trust Stoke Therapeutics Inc [2021-06-30] 0.0
Redmile Group LLC Stoke Therapeutics Inc [2021-02-16] 7.4
FMR LLC Stoke Therapeutics Inc [2021-02-08] 0.0
Gilder Gagnon Howe & Co LLC Stoke Therapeutics Inc [2020-02-14] 5.58
Cormorant Asset Management LP Stoke Therapeutics Inc [2019-07-01] 2.45
Apple Tree Partners IV LP Stoke Therapeutics Inc [2019-07-01] 51.4
RTW Investments LP Stoke Therapeutics Inc [2019-06-28] 10.67
Form 3/4/5 Filer 2011 - 2026
Stoke Therapeutics Inc
Ticho Barry
Allan Jonathan
Smith Julie
Krainer Adrian R
Kaye Edward M MD
Levin Arthur A
Tzianabos Arthur
Harrison Seth Loring
Burstein Jennifer
Kahn Clare
Hoitt Jason
Leggett Thomas
Smith Ian F
Montrago Trustees Ltd
Skorpios Trust
Blue Horizon Enterprise Ltd
Ezbon International Ltd
Menzel Garry E
Nash Huw M
Tulipano Stephen J
ATP Life Science Ventures LP
ATP III GP Ltd
Liau Gene
Walker Robin A
Wong Roderick
RTW Investments LP
Hall Samuel W
Redmile Group LLC
Green Jeremy
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Allan Jonathan
Common Stock
2026-03-20 Sell 601 $34.41 20,680
Allan Jonathan
Common Stock
2026-03-20 Sell 8,692 $33.64 292,399
Ticho Barry
Stock Option (Right to Buy) · derivative
2026-03-19 Option exercise 1,365 $0.00
Ticho Barry
Common Stock
2026-03-19 Option exercise 1,365 $2.19 2,989
Ticho Barry
Common Stock
2026-03-19 Sell 1,461 $29.99 43,815
Hoitt Jason
Common Stock
2026-03-18 Sell 139 $31.79 4,419
Leggett Thomas
Common Stock
2026-03-18 Sell 37 $32.85 1,215
Leggett Thomas
Common Stock
2026-03-18 Sell 172 $31.79 5,468
Allan Jonathan
Common Stock
2026-03-18 Sell 4,222 $31.28 132,064
Allan Jonathan
Common Stock
2026-03-18 Sell 334 $31.79 10,618
Allan Jonathan
Common Stock
2026-03-18 Sell 72 $32.85 2,365
Leggett Thomas
Common Stock
2026-03-18 Sell 2,173 $31.28 67,971
Hoitt Jason
Common Stock
2026-03-18 Sell 1,762 $31.28 55,115
Ticho Barry
Common Stock
2026-03-18 Sell 6,100 $31.28 190,808
Ticho Barry
Common Stock
2026-03-18 Sell 103 $32.85 3,384
Hoitt Jason
Common Stock
2026-03-18 Sell 30 $32.85 986
Ticho Barry
Common Stock
2026-03-18 Sell 483 $31.79 15,355
Allan Jonathan
Common Stock
2026-03-17 Sell 1,791 $33.38 59,784
Leggett Thomas
Common Stock
2026-03-17 Sell 922 $33.38 30,776
Ticho Barry
Common Stock
2026-03-17 Sell 2,587 $33.38 86,354
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 196 69,340,344
2025-12-31 185 67,243,569
2025-09-30 154 68,215,805
2025-06-30 134 65,730,671
2025-03-31 128 63,526,533
2024-12-31 131 58,299,113
2024-09-30 120 58,657,843
2024-06-30 116 62,595,931
2024-03-31 107 62,684,640
2023-12-31 82 48,633,235
2023-09-30 99 44,045,120
2023-06-30 101 46,781,280
Form 13F Holdings
Firm Period DFND Voting Shares
Assenagon Asset Management SA [2026-06-30] SOLE 1,128,388 1,128,388
Generali Investments Management Co LLC [2026-06-30] SOLE 33,149 33,149
PSP Research LLC [2026-06-30] SOLE 0 12,000
TEMA ETFS LLC [2026-06-30] SOLE 9,917 9,917
Versant Capital Management Inc [2026-06-30] SOLE 1,951 1,951
Gamma Investing LLC [2026-06-30] DFND 883 883
Owl Creek Wealth Partners LLC [2026-06-30] SOLE 0 150
Dogwood Wealth Management LLC [2026-06-30] SOLE 24 24
Farther Finance Advisors LLC [2026-06-30] SOLE 0 17
IFP Advisors LLC [2026-06-30] SOLE 5 5
True Wealth Design LLC [2026-06-30] SOLE 0 4
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com